Summary
Reducing lead times of medicinal drugs to the market by reducing process development and clinical testing timeframes is a critical driver in increasing EU (bio)pharmaceutical industry competitiveness. Despite new therapeutic principles or regulatory initiatives to enable more...
More information & hyperlinks
| Web resources: | http://www.bio-rapid.eu/ |
